Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line

被引:32
作者
García-Lora, A [1 ]
Martinez, M [1 ]
Pedrinaci, S [1 ]
Garrido, F [1 ]
机构
[1] Univ Granada, Hosp Univ Virgen Nieves, Serv Anal Clin & Inmunol, Granada 18014, Spain
关键词
cancer immunotherapy; interleukin-2; MAPK; NK cell; PKC isoenzyme; PSK;
D O I
10.1007/s00262-002-0336-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The activation of natural killer (NK) cells and induction of cytotoxicity are complex processes whose molecular mechanisms have not been clearly elucidated. Stimulation of the NKL human NK cell line with interleukin-2 (IL-2) or protein-bound polysaccharide K (PSK) leads to sustained growth and cytolytic activity in comparison to unstimulated NKL cells. Our previous results shown that IL-2 and PSK regulate different nuclear transcription factors in NKL cells, and that the signal transduction pathway used by these inducers is different. To determine the molecular basis for the different action of IL-2 and PSK, we investigated the upstream effects generated in human NKL cells by IL-2 and PSK on protein kinase C (PKC) isoenzymes and mitogen-activated protein kinases (MAPK). Here we report the profile of unstimulated NKL cells as: PKCbeta > PKCalpha > PKCdelta = PKCepsilon. The PKCeta form was not expressed. The effects of PSK and IL-2 on these isoenzymes were different. IL-2 increased the expression of PKCalpha, PKCdelta and PKCepsilon, whereas PSK decreased the expression of PKCalpha, and also increased PKCdelta and PKCepsilon to higher levels than did IL-2. In MAPK expression we found that unstimulated NKL cells have the following profile: ERK2>ERK6>p38gamma>p38beta> ERK1. ERK3, ERK3 rel, ERK5/ERK4 and p38delta were not expressed. IL-2 decreased the expression of ERK2, whereas PSK did not, and both agents increased the expression of ERK3. These results shown that PSK and IL-2 produce different variations in PKC isoenzymes and MAPK in NKL cells.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 35 条
[1]  
Algarra I, 1997, J EXP CLIN CANC RES, V16, P373
[2]  
Algarra I, 1999, J EXP CLIN CANC RES, V18, P39
[3]   T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation [J].
Crawley, JB ;
Rawlinson, L ;
Lali, FV ;
Page, TH ;
Saklatvala, J ;
Foxwell, BMJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :15023-15027
[4]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72
[5]  
FAIRHURST RM, 1993, IMMUNOLOGY, V79, P112
[6]   Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line [J].
García-Lora, A ;
Pedrinaci, S ;
Garrido, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (04) :191-198
[7]  
Gollob JA, 1999, J IMMUNOL, V162, P4472
[8]   THE ZETA-ISOFORM OF PROTEIN-KINASE-C CONTROLS INTERLEUKIN-2-MEDIATED PROLIFERATION IN A MURINE T-CELL LINE - EVIDENCE FOR AN ADDITIONAL ROLE OF PROTEIN-KINASE-C-EPSILON AND PROTEIN-KINASE-C-BETA [J].
GOMEZ, J ;
PITTON, C ;
GARCIA, A ;
DEARAGON, AM ;
SILVA, A ;
REBOLLO, A .
EXPERIMENTAL CELL RESEARCH, 1995, 218 (01) :105-113
[9]   Activation and signal transduction via mitogen-activated protein (MAP) kinases in T lymphocytes [J].
Hardy, K ;
Chaudhri, G .
IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (06) :528-545
[10]   Protein kinase Cθ in T cell activation [J].
Isakov, N ;
Altman, A .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :761-794